Skip to content

Phloroglucinol Effectiveness on Shortening the Duration of Active Phase of Labor

Effect of Phloroglucinol on Shortening the Duration of Active Phase of Labor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07184099
Enrollment
134
Registered
2025-09-19
Start date
2025-01-01
Completion date
2025-06-30
Last updated
2025-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor

Brief summary

This study was planned to fill the gaps regarding the effectiveness of phloroglucinol on the duration of active phase of labor.

Detailed description

In today's era, the focus has shifted from a wait and watch policy to active intervention sooner than later to enhance better labor outcomes. Using an ideal antispasmodic drug would help achieve a rapid and prolonged effect on cervical dilation, with no adverse impact on uterine contractions or causing uterine inertia. If the current study finds phloroglucinol effective in shortening the duration of the active phase of labor, it would help achieve better patient outcomes.

Interventions

Phloroglucinol was administered as intravenous stat infusion with Ringer Lactate infusion.

Sponsors

Muhammad Aamir Latif
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant women aged between 18-35 years * Period of gestation above 37 weeks.

Exclusion criteria

* Women with cephalopelvic disproportion * Double scare uterus * Fetal distress * Life threatening bleeding * Eclampsia * History of heart disease * Known allergy to phloroglucinol

Design outcomes

Primary

MeasureTime frameDescription
Duration of labor4 hoursThe duration of labor was measured from the time of diagnosis of labor until full dilatation of cervix.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026